Use of ic tags in short-term carcinogenicity study on CB6F1 TGrasH2 mice

Journal of Toxicological Sciences

Volumn 31, Issue 5, 2006, Pages 407-418

  Urano, Koji ^a   Suzuki, Syuzo ^a   Machida, Kazuhiko ^a   Sawa, Nobuko ^a   Eguchi, Natsuko ^a   Kikuchi, Koji ^b   Fukasawa, Kazumasa ^b   Taguchi, Fukushi ^b   Usui, Toshimi ^a  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b JAC Inc ^*  (Japan)

Author keywords

Carcinogenicity test; Genetic modified mice; IC tag; Microchip; Polypropylene; rasH2 mice

Indexed keywords

ACETONE; METHYLNITROSOUREA; PHORBOL 13 ACETATE 12 MYRISTATE; POLYPROPYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SURFACE; BODY WEIGHT; CANCER INCIDENCE; CANCER RESEARCH; CARCINOGENESIS; CARCINOGENICITY; COMPUTER PROGRAM; CONTROLLED STUDY; DEVICE; DNA MODIFICATION; FEMALE; IDENTIFICATION KEY; IMPLANTATION; INTEGRATED CIRCUIT; KERATOACANTHOMA; MALE; MICROCHIP ANALYSIS; MOUSE; NONHUMAN; ONCOGENE C H RAS; PAPILLOMA; TECHNIQUE;

ANIMALIA;

EID: 33845970595     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.31.407     Document Type: Article

References (18)

1. Ball, D.J., Argentieri, G., Krause, R., Lipinski, M., Robinson, R.L., Stoll, R.E. and Visscher, G.E. (1991): Evaluation of a microchip implant system used for animal identification in rats. Lab. Anim. Sci., 41, 185-186.
2. Blanchard, K.T., Barthel, C., French, J.E., Holden, H.E., Moretz, R., Pack, F.D., Tennant, R.W. and Stoll, R.E. (1999): Transponder-induced sarcoma in the heterozygous p53+/- mouse. Toxicol. Pathol., 27, 519-527.
3. Eastin, W.C., Mennear, J.H., Tennant, R.W., Stoll, R.E. , Branstetter, D.G., Buche r, J . R . , McCullough, B., Binder, R. L., Spalding, J.W. and Mahler, J.F. (2001): Tg.AC genetically altered mouse: Assay working group overview of available data. Toxicol. Pathol., 29 (Suppl.), 60-80.
4. Elcock, L.E., Stuart, B.P., Wahle, B.S., Hoss, H.E., Crabb, K., Millard, D.M., Mueller, R.E., Hastings, T.F. and Lake, S.G. (2001): Tumors in long-term rat studies associated with microchip animal identification devices. Exp. Toxicol. Pathol., 52, 483-491.
5. French, J., Storer, R.D. and Donehower, L.A. (2001): The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. Toxicol. Pathol., 29 (Suppl.), 24-29.
6. Holden, H.E., Stall, R.E., Spalding, J.W. and Tennant, R.W. (1998): Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: Evaluation of husbandry and housing factors. J. Appl. Toxicol., 18, 19-24.
7. Ingwersen, W. (1996): Everything you ever wanted to know about microchips. Can. Vet. J., 37, 667-671.
8. MacDonald, J., French, J.E., Gerson, R.J., Goodman, J., Inoue, T., Jacobs, A., Kasper, P., Keller, D., Lavin, A., Long, G., McCullough, B., Sistare, F.D., Storer, R. and van der Laan, J.W. (2004): The utility of genetically modified mouse assays for identifying human carcinogens: A basic understanding and path forward. Toxicol. Sci., 77, 188-194.
9. Mrozek, M., Fischer, R., Trendelenburg, M. and Zillmann, U. (1995): Microchip implant system used for animal identification in laboratory rabbits, guinea pigs, woodchucks and in amphibians. Lab. Anim., 29, 339-344.
10. Ohkawa, Y., Iwata, K. and Inui, N. (1988): Screening for skin-tumor promoters. Biomed. Pharmacother., 42, 447-450.
11. Radman, M. and Kinsella, A.R. (1980): Chromosomal events in carcinogenic initiation and promotion: Implications for carcinogenicity testing and cancer prevention strategies. IARC Sci. Publ., 27, 75-90.
12. Rao, G.N. and Edmondson, J. (1990): Tissue reaction to an implantable identification device in mice. Toxicol. Pathol., 18, 412-416.
13. Sacco, W. (1992): Microchip implant for positive animal identification. Am. Biotechnol. Lab., 10, 16-17.
14. Takaoka, M., Sehata, S., Maejima, T., Imai, T., Torii, M., Satoh, H., Toyosawa, K., Tanakamaru, Z., Adachi, T., Hisada, S., Ueda, M., Ogasawara, H., Matsumoto, M., Kobayashi, K., Mutai, M. and Usui, T. (2003): Interlaboratory camparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Toxicol. Pathol., 31. 191-199.
15. Tamaoki, N. (2001): The rasH2 transgenic mouse: Nature of the model and mechanistic studies on tumorigenesis. Toxicol. Pathol., 29 (Suppl.), 81-89.
16. Tillmann, T., Kamino, K., Dasenbrock, C., Ernst, H., Kohler, M., Morawietz, G., Campo, E., Cardesa, A., Tomatis, L. and Mohr, U. (1997): Subcutaneous soft tissue tumors at the site of implanted microchips in mice. Exp. Toxicol. Pathol., 49, 197-200.
17. Usui, T., Mutai, M., Hisada, S., Takaoka, M., Soper, K.E., McCullough, B. and Alden, C. (2001): CB6F1-rasH2 mouse: Overview of available data. Toxicol. Pathol., 29 (Suppl.), 90-108.
18. Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori , K. , Kurokawa, Y., Hayashi, Y. and Nomura, T. (1998): Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for carcinogenicity testing. Environment. Health Perspect., 106 (Suppl.1), 57-69.